Company news
PolyPid Ltd. news in 2020
PolyPid Ltd.'s news releases, calls and decks from 2020, newest first.
PolyPid Announces Positive Preclinical Data from OncoPLEX Intra-Tumoral Cancer Therapy Program
December 21, 2020
PolyPid Initiates SHIELD II: Second Phase 3 Clinical Trial of D-PLEX₁₀₀ for the Prevention of Post-Abdominal Surgery Incisional Infections
December 15, 2020
PolyPid Granted Breakthrough Therapy Designation from FDA for D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Colorectal Surgery
November 23, 2020
PolyPid Ltd. Provides Corporate Update and Reports Third Quarter 2020 Financial Results
November 10, 2020
PolyPid Ltd. Provides Corporate Update and Reports Second Quarter 2020 Financial Results
August 18, 2020
PolyPid Granted Fast Track Designation from FDA for D-PLEX₁₀₀ for Prevention of Surgical Site Infections in Abdominal Surgery
August 2, 2020
PolyPid Initiates First Phase 3 Clinical Trial of D-PLEX100 for the Prevention of Post-Abdominal Surgery Incisional Infections
June 30, 2020
PolyPid Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
June 29, 2020
Decks in 2020
- Technical Presentation (December 2020)
Technical · 39 slides · Dec 15, 2020